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SUMMARY We present a case of an ulcerative lesion of the genitalia 
starting one year before in a 33-year-old man. Histopathologic 
examination revealed herpes virus infection, which suggested 
the existence of cell-mediated immunodeficiency. Human 
immunodeficiency virus (HIV) infection was confirmed by ELISA 
and Western blot test. The patient was treated with intravenous 
acyclovir, which led to complete remission. We underline the 
importance of early detecting and diagnosing patients with 
similar clinical manifestation as a sign of significant underlying 
immunodeficiency.
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IntRodUCtIon
Genital herpes is a sexually transmitted viral 
infection, characterized by primary infection with 
grouped vesicles at the site of inoculation and a 
course of recurring outbreaks of vesicles at the 
same site. It is caused by herpes simplex virus 
type 2 (HSV-2) and less commonly by herpes 
simplex virus type 1 (HSV-1). In an immunocom-
promised host, HSV-2 may cause extensive lo-
cal infection with chronic herpetic ulcers or even 
widespread systemic infection. Herpetic lesions 
can sometimes be misleading and an accurate di-
agnosis may not be reached at the patient’s first 
encounter with the physician. HSV-2 infections 
may often be unrecognized as lesions of viral ori-
gin, but may be ignored or mistakenly diagnosed 
as urinary tract infection, candidal yeast infection, 
allergy, factitial dermatitis, or other genital condi-
tions (1). Improved diagnosis of HSV-2 infection 
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could reduce inappropriate use of antibiotics and 
antifungal medications, as well as enable patients 
to receive effective treatment and take appropriate 
precautions to prevent the spread of the disease.
CASe RepoRt
A 33-year-old male was admitted for painful 
ulcerative lesions of the genitalia which had de-
veloped within the past twelve months and had 
persisted ever since. His medical history included 
β-thalassemia trait and schizophrenia (satisfac-
torily controlled with drug therapy). He also com-
plained of recurrent symptomatic HSV-2 genital 
infections over the past eight years. The patient 
reported a weight loss of approximately 10 kg and 
several recurrent episodes of high fever during the 
past year. In this period, he visited several phy-
sicians and was initially given systemic antibiotic 
treatment for a diagnosis of perianal fistula, while 
on the next visits he was administered local antibi-
otics and corticosteroids plus systemic antibiotics 
for suspected recurrent febrile bacterial infections. 
During the last ten days, the patient reported anti-
pyretic-resistant hyperpyrexia. On referral he was 
febrile with a temperature of 39.8 oC, blood pres-
sure of 125/80 mm Hg and heart rate of 116 beats/
min. Physical examination only revealed cachexia 
and paleness. White plaques were observed in the 
soft palate and uvula (Fig. 1). Cutaneous findings 
consisted of extended bilateral painful ulcerative 
lesions of the scrotum, penis, crural folds and 
thighs, which extended to the gluteal cleft area 
and buttock (Figs. 2 and 3).
The lesions were covered with pus and hem-
orrhagic exudate. Satellite papules and vesicles 
coexisted on healthy skin surrounding the main 
lesions. No other systemic involvement was rec-
ognized. Results of laboratory studies were as 
follows: hemoglobin 7.4 g/dL, hematocrit 24.2%, 
white blood cell count 6000/μL (82% neutrophil 
leukocytes, 11% lymphocytes), erythrocyte sedi-
mentation rate 122 mm/1 h, albumins 23 g/L, and 
Figure 1. White plaques covering the soft palate 
and uvula of the patient.
Figures 2 and 3. Bilateral painful ulcerative lesions extending to the gluteal cleft area and buttock.
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globulins 42g/L. The remaining serum biochemis-
try and urinalysis results were all within the ref-
erence range. Culture of the ulcerated areas iso-
lated a strain of β-hemolytic Streptococcus group 
F, while Candida albicans was isolated from the 
soft palate exudate. Histopathologic examination 
revealed disseminated intraepidermal vesicles 
which contained inflammatory cells. Several epi-
thelial cells were multinucleated and contained 
intranuclear inclusions characteristic of HSV-2 in-
fection (Fig. 4).
HSV-2 antigen was detected on the epithelial 
cells of the lesion using direct immunofluorescence 
techniques (BIORAD Laboratories). The Herpe-
Select Elisa IgG test (Focus Diagnostics) revealed 
type specific antibodies to HSV-2, whereas IgM 
antibodies were negative. An in-house developed 
PCR was also positive for HSV-2. The patient’s 
history and clinical presentation in conjunction 
with the diagnosis of HSV-2 infection and atypi-
cal nature of the lesions (widespread, ulcerated 
and chronic) were highly suggestive of a possible 
underlying acquired immunodeficiency. Our pa-
tient reported that he had never been tested for 
human immunodeficiency virus (HIV) infection be-
fore. The HIV-1 infection was confirmed by both 
ELISA and Western blot methods, while the CD4 
lymphocyte count revealed 114 cells/mm3 (16%) 
and CD8 436 cells/mm3 (61%). HBsAg and anti-
HCV tests were negative. The patient was treated 
with intravenous acyclovir, 500 mg every 8 hours 
for three weeks. Immediate fever remission and 
progressive regression of the cutaneous lesions 
with marked pain reduction were observed shortly 
after therapy initiation. For oral candidiasis he was 
treated with per os fluconazole, 100 mg twice a 
day for two weeks, which resulted in reduction of 
the white exudate.
dISCUSSIon
MEDLINE was searched using the key words 
HSV-2 and HIV. Articles on HSV-2, its epidemiol-
ogy and interaction with HIV were reviewed. The 
seroprevalence of HSV-2 antibodies varies con-
siderably among various populations and ethnic 
groups, and it has increased over the past few 
years (2). Most of the infected persons are either 
asymptomatic or, more commonly, have genital 
symptoms that remain unrecognized (3,4). HSV 
infections manifesting with persistent anogenital 
lesions were among the first opportunistic infec-
tions to be described in persons with acquired im-
mune deficiency syndrome (AIDS) (5). Moreover, 
several studies have shown that HIV-induced im-
mune impairment results in severe, persistent and 
recurrent genital herpes, as well as in frequent 
subclinical reactivations (6,7). HSV-2 shedding is 
significantly associated with HIV serostatus and 
CD4 cell count <200/mm3 (8). In recent years, a 
strong epidemiologic association has emerged 
between HSV-2 and HIV infection. Numerous 
studies have proved that HSV-2 seroprevalence 
rates are higher in HIV-positive than in HIV-nega-
tive persons (9-14). Similarly to HIV, serologic di-
agnosis of HSV-2 infection has been suggested 
as a marker of lifestyle and sexual behavior (3). In 
addition, there is evidence that serologically docu-
mented HSV-2 infection is a significant risk fac-
tor for HIV acquisition (15). Several epidemiologic 
studies have demonstrated that prevalent HSV-
2 is associated with a 2- to 4- fold risk of HIV-1 
acquisition (7,15). Considering the particular and 
extensive clinical presentation of the herpetic in-
fection in our patient, we were surprised to find the 
lesion history to have extended to a period of ap-
proximately 12 months back. It seems that in our 
case, the majority of physicians involved actually 
misdiagnosed the herpetic infection as being of 
bacterial origin, without considering the possibility 
of an atypical manifestation of a viral infection in 
an immunocompromised host. This probably oc-
curred because of the great extension and severity 
of the lesions and of their atypical form, combined 
with systemic manifestations (fever, anemia, ca-
chexia). Despite the fact that eventually the patient 
responded favorably to the treatment, such a de-
lay in attaining an accurate diagnosis had affected 
the patient since he had undergone unnecessary 
administration of several antibiotics, suffered for 
a longer period while having a low quality of life, 
and finally much valuable time was wasted before 
diagnosing the HIV co-infection, while the patient 
could have also contaminated other individuals 
during the period of undiagnosed high viral load.
Figure 4. Histopathologic examination character-
istic of HSV-2 infection.
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In conclusion, we report a case of chronic, ex-
tensive and atypical HSV-2 infection in an HIV-1 
infected patient, emphasizing the fact that in HIV-
positive patients, herpetic infection can differ from 
the classic form and highlighting the importance 
of similar cases as an alerting clinical sign of 
profound cellular immune depression. We would 
also suggest that physicians should on some oc-
casions lower the generally used and widely ac-
cepted threshold for offering HIV testing (always in 
accordance with the clinical picture of every indi-
vidual patient), with any particular clinical presen-
tation and according to the most recent guidelines, 
even as part of routine care.
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